Kemal Malik serves as Executive at ACCELERON PHARMA INC, where they oversee executive responsibilities. Since joining the company, Kemal Malik has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 1, 2024 involved receiving (via award) 5,933 shares valued at $0.
Kemal Malik currently holds 5,933 shares of ACCELERON PHARMA INC (XLRN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kemal Malik has been a net neutral trader of XLRN stock. They have purchased $0 and sold $0 worth of shares.
Kemal Malik's most recent insider trade was on Jul 1, 2024, when they sold 5,933 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 29, 2021 | XLRN | $0 | Award | 1,622 | $N/A | Discretionary |